Lataa...

Predictive value of clinical toxicities of chemotherapy with fluoropyrimidines and oxaliplatin in colorectal cancer by DPYD and GSTP1 gene polymorphisms

BACKGROUND: Fluoropyrimidines and platinum are still widely used for colorectal cancer (CRC) management. Several studies have reported that mutations of dihydropyrimidine dehydrogenase (DPYD) and glutathione S-transferase pi-1 (GSTP1) polymorphisms are related to chemotherapy-related adverse events....

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:World J Surg Oncol
Päätekijät: Deng, Xunwei, Hou, Jingyuan, Deng, Qiaoting, Zhong, Zhixiong
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2020
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7720377/
https://ncbi.nlm.nih.gov/pubmed/33280607
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12957-020-02103-3
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!